Students of the MBA-MCI program are on a study tour to Shanghai, China from March 3-8, 2024, led by Professor Andreas Hinz, Director of MBA-MCI program, FHNW.
On March 3, the delegation had a meeting with representatives of the Chinese company Teva Pharmaceuticals and heard sharing and introduction about Teva Pharmaceuticals – one of the largest pharmaceutical companies in the world with offices in many countries.
On March 4, the delegation continued to visit Kuehne+Nagel – a global logistics operator, and Swiss Centers Shanghai – a non-profit organization providing support services to small and medium-sized Swiss enterprises investing in the Chinese market and the Shanghai Free Trade Zone (FTZ).
The MBA-MCI program includes experiential learning opportunities overseas that exhibit a high level of practical applicability and give students access to real-world settings in communities, corporations, and organizations, connect with MBA-MCI students and alumni, thereby contributing to improving the management, innovation and creativity capacity of students.
The following activities from the MBA-MCI students’ study trip to China will be updated.
A few images from the study trip
